ENSOMA
Ensoma is expanding the reach of the curative power of genomic medicine by pioneering a next-generation in vivo approach using its Engenious™ vectors. Ensoma’s vectors are designed to deliver a diverse range of gene modification technologies without the need for stem cell collection or prior myeloablative conditioning (e.g., chemotherapy). As a result, Ensoma’s therapies can be delivered as a single injection in a diverse range of settings, including outpatient and settings where access to sophisticated healthcare systems may be limited.
ENSOMA
Industry:
Biotechnology Genetics Therapeutics
Founded:
2019-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.ensoma.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
70 M USD
Technology used in webpage:
SSL By Default LetsEncrypt Content Delivery Network Mobile Non Scaleable Content Nginx Amazon Apple Mobile Web App Capable Amazon S3 CDN Apple Mobile Web App Status Bar Style Java EE
Similar Organizations
Accent Therapeutics
Accent Therapeutics is a biopharmaceutical company.
Arkuda Therapeutics
Arkuda Therapeutics is a pharmaceutical company.
Calimmune
Calimmune is a clinical-stage gene therapy company.
Celsius Therapeutics
Celsius Therapeutics is a biotechnology company that develops precision medicines for cancer and autoimmune disease patients.
Chroma Medicine
Chroma Medicine is a new genomic medicine company working on epigenetic editing.
Genome Technology Access Center
A full-service genomics service company
ImmuneID
ImmuneID is a precision immunology company.
CareDx
CareDx is a novel molecular diagnostics company.
Current Advisors List
Current Employees Featured
Founder
Investors List
Takeda Ventures
Takeda Ventures investment in Series A - Ensoma
Viking Global Investors
Viking Global Investors investment in Series A - Ensoma
5AM Ventures
5AM Ventures investment in Series A - Ensoma
RIT Capital Partners
RIT Capital Partners investment in Series A - Ensoma
SymBiosis LLC
SymBiosis LLC investment in Series A - Ensoma
Alexandria Venture Investments
Alexandria Venture Investments investment in Series A - Ensoma
F-Prime Capital
F-Prime Capital investment in Series A - Ensoma
Cormorant Asset Management
Cormorant Asset Management investment in Series A - Ensoma
Key Employee Changes
| Date | New article |
|---|---|
| 2021-10-11 | Ensoma Taps Gene Therapy Leader as First CEO |
Official Site Inspections
http://www.ensoma.com
- Host name: 63.2.231.35.bc.googleusercontent.com
- IP address: 35.231.2.63
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Ensoma"
Ensoma - Crunchbase Company Profile & Funding
Ensoma’s vectors are designed to deliver a diverse range of gene modification technologies without the need for stem cell collection or prior myeloablative conditioning (e.g., chemotherapy). As a result, Ensoma’s therapies can be …See details»
Inside Ensoma – Ensoma
Inside Ensoma Ensoma /en’sōmə/ is derived from the Greek phrase “en soma,” meaning in the body. Our vision is a new genomic medicine based on engineering hematopoietic stem cells …See details»
Ensoma Company Profile | Management and Employees List
Ensoma Profile and History. Ensoma believes the future of medicine lies within us. Our Engenious gene therapy platform is the first to precisely engineer any or all hematopoietic and immune …See details»
Ensoma Company Profile 2024: Valuation, Funding
Ensoma was founded in 2019. Where is Ensoma headquartered? Ensoma is headquartered in Boston, MA. What is the size of Ensoma? Ensoma has 120 total employees. What industry is Ensoma in? Ensoma’s primary industry is Drug …See details»
Careers - Ensoma
Our generous and competitive benefits and wellness package play a critical role in supporting our team and their families. Ensoma offers a comprehensive package including medical, dental and vision coverage, life and disability …See details»
Ensoma - Company Profile & Staff Directory - ContactOut
Ensoma /en’sōmə/ is derived from the Greek phrase “en soma,” meaning in the body. We develop one-time in vivo treatments that precisely engineer any or all blood and immune cells to cure …See details»
Ensoma, Inc. Company Profile | Boston, MA - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Ensoma, Inc. of Boston, MA. Get the latest business insights from Dun & Bradstreet.See details»
Ensoma - Company Profile - Tracxn
Oct 22, 2024 Ensoma ranks 42nd among 680 active competitors. 245 of its competitors are funded while 148 have exited. Overall, Ensoma and its competitors have raised over $20.2B in …See details»
Ensoma - Company profile | ensun
Rob Peters brings to Ensoma more than 20 years of research and development experience, including working on recombinant clotting Factor VIII and Factor IX Fc fusion proteins from …See details»
A Brief History of Ensoma – CBM - canvasbusinessmodel.com
A Brief History of Ensoma Ensoma, a groundbreaking biotech company, was founded in 2015 with a clear vision to revolutionize healthcare through cutting-edge genetic therapies. From its …See details»
Ensoma debuts with $70M, Takeda deal to pursue off-the-shelf …
Feb 11, 2021 Ensoma hopes to change that with a suite of off-the-shelf genomic medicines. The company launches with $70 million in venture financing as well as a partnership with Takeda …See details»
Ensoma buys a startup to advance ‘in vivo’ cell therapy work
Jan 6, 2023 Dive Brief: In twin announcements Thursday, Ensoma said it will acquire the startup Twelve Bio and revealed $85 million in new financing to advance its ‘in vivo’ cell therapy …See details»
Ensoma Unveils Three Programs Leveraging In Vivo Hematopoietic …
BOSTON, November 05, 2024--Ensoma has unveiled its three lead programs in chronic granulomatous disease (CGD), sickle cell disease (SCD) and solid tumors.See details»
How Does Ensoma Work? - CBM
Oct 2, 2024 Ensoma is a revolutionary biotech company that utilizes cutting-edge technologies to develop revolutionary gene therapies for a wide range of genetic diseases. The company's …See details»
Pipeline – Ensoma
At Ensoma, we are advancing the future of medicine through in vivo hematopoietic stem cell (HSC) engineering. Our three lead programs target critical unmet needs in X-linked chronic …See details»
Mission, Vision & Core Values of Ensoma - CBM
Ensoma, a genomic medicine company, is dedicated to making a collective impact on healthcare through its innovative one-time in vivo treatments for immuno-oncology and other therapeutic …See details»
Our Science - Ensoma
Our focus is one-time, off-the-shelf therapies that redesign the hematopoietic system to treat diseases with unprecedented versatility. We achieve this by directly engineering the master …See details»
Ensoma Launches to Pioneer Next-Generation In Vivo Approach to …
Feb 11, 2021 Ensoma was founded by and incubated within the 4:59 Initiative, the company creation engine of 5AM Ventures. The company’s scientific co-founders include Dr. Hans …See details»
News - Ensoma
Jan 5, 2023 Ensoma Appoints Accomplished Company Builder and Product Developer, Jim Burns, Ph.D., as Chief Executive Officer. May 16, 2023. Ensoma Closes Series B Extension, …See details»